Delivery Order SPE2DB22D3501-SPE2DB25FVQ27

Award Date 5/9/25
Potential Completion Date 5/12/25
Potential Value $3.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of dexamethasone 10 mg/ml vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $1,943.20. This is a delivery order contract with a firm-fixed price pricing type. The period of performance runs through April 26, 2024. The contract was awarded on April 25, 2022 and did not utilize any set-aside designations, indicating open...
This federal contract award, valued at $9,859.00, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Dexamethasone 10 mg/mL vials, a medication used to treat various medical conditions. This is a Firm Fixed Price delivery order contract, with an ultimate completion date of April 24, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the prime contractor, and this...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,524.24, is a Firm Fixed Price Delivery Order for the supply of Dexamethasone 10 mg/ml vials. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award, valued at $3,742.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4565662754 DEXAMETHASONE 20 MG/5 ML VIAL 5ML, a pharmaceutical product, with a completion date of September 4, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award issued by the Defense Logistics Agency (DLA) is for the purchase of dexamethasone 10 mg/mL vials. The award, valued at $1,013.61, was made on May 23, 2023 to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of May 24, 2023 and is a firm fixed price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of dexamethasone 10 mg/mL vials. The contract, worth $1,862.79, is a firm fixed-price delivery order with a completion date of May 30, 2024. Amerisourcebergen, through its Corporate Office division, is fulfilling this order as part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,153.03 firm fixed-price contract involves the delivery of 4557473394 - Dexamethasone 20 mg/5 ml vial, 5 ml. The award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC...
This is a delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,565,911,624 units of Dexamethasone 20 mg/5 ml vials, a critical medication. The order has a firm fixed price of $5,562.90 and a completion date of September 24, 2024. Amerisourcebergen, through its extensive pharmaceutical supply chain, will provide this medication to support various military treatment...
This federal contract award is a delivery order with a ceiling value of $1,652.20 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DEXAMETHASONE 20 MG/5 ML VIAL 5ML medical supplies. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,332.76, is for the delivery of 4566894436 ! DEXAMETHASONE 20 MG/5 ML VIAL 5ML, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. This IDC serves as a...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVQ27
    Delivery Order

This federal contract award is for the delivery of dexamethasone 10 mg/ml vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and does not have a set-aside designation, indicating open competition. The contract has a firm fixed price pricing type and a ceiling value of $3,080.56. It is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999.00, which provides comprehensive global pharmaceutical support to military healthcare programs through December 2026. This award aligns with the DLA's role in supplying diverse medical products, including prescription medications, to support federal agency requirements, particularly for military and veteran healthcare systems.

Generated 8/8/25, 9:46 AM